Limits...
oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.

Nickel T, Pfeiler S, Summo C, Kopp R, Meimarakis G, Sicic Z, Lambert M, Lackermair K, David R, Beiras-Fernandez A, Kaczmarek I, Weis M - Mediators Inflamm. (2012)

Bottom Line: CCL21- and CCR7-mRNA levels were significantly downregulated in atherosclerotic plaques versus non-atherosclerotic controls [90% for CCL21 and 81% for CCR7 (P < 0.01)].In vitro, oxLDL reduced CCR7 mRNA levels on DCs by 30% and protein levels by 46%.Furthermore, mRNA expression of CCL21 was significantly reduced by 50% (P < 0.05) and protein expression by 24% in HMECs by oxLDL (P < 0.05).

View Article: PubMed Central - PubMed

Affiliation: Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians University, 81377 Munich, Germany. tsnickel@web.de

ABSTRACT

Introduction: Dendritic cells (DCs) and oxLDL play an important role in the atherosclerotic process with DCs accumulating in the plaques during plaque progression. Our aim was to investigate the role of oxLDL in the modulation of the DC homing-receptor CCR7 and endothelial-ligand CCL21.

Methods and results: The expression of the DC homing-receptor CCR7 and its endothelial-ligand CCL21 was examined on atherosclerotic carotic plaques of 47 patients via qRT-PCR and immunofluorescence. In vitro, we studied the expression of CCR7 on DCs and CCL21 on human microvascular endothelial cells (HMECs) in response to oxLDL. CCL21- and CCR7-mRNA levels were significantly downregulated in atherosclerotic plaques versus non-atherosclerotic controls [90% for CCL21 and 81% for CCR7 (P < 0.01)]. In vitro, oxLDL reduced CCR7 mRNA levels on DCs by 30% and protein levels by 46%. Furthermore, mRNA expression of CCL21 was significantly reduced by 50% (P < 0.05) and protein expression by 24% in HMECs by oxLDL (P < 0.05).

Conclusions: The accumulation of DCs in atherosclerotic plaques appears to be related to a downregulation of chemokines and their ligands, which are known to regulate DC migration. oxLDL induces an in vitro downregulation of CCR7 and CCL21, which may play a role in the reduction of DC migration from the plaques.

Show MeSH

Related in: MedlinePlus

mRNA expression of CCL21/19, CCR7, and CD83 in vascular plaques compared to aortic tissue without plaque detection. In vivo changes (relative fold increases) in mRNA expression of CCL19, CCL21, CCR7, and CD83 in carotid plaques compared to healthy aortic material. *P < 0.05, **P < 0.01, (n = 47) versus aortic tissue (n = 14).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3350855&req=5

fig1: mRNA expression of CCL21/19, CCR7, and CD83 in vascular plaques compared to aortic tissue without plaque detection. In vivo changes (relative fold increases) in mRNA expression of CCL19, CCL21, CCR7, and CD83 in carotid plaques compared to healthy aortic material. *P < 0.05, **P < 0.01, (n = 47) versus aortic tissue (n = 14).

Mentions: Further analysis of CCL19 revealed that its transcripts were downregulated by 99% (P < 0.01). CCL21 was found 90% lower in the plaque (P < 0.01) compared to healthy aortic tissue (Figure 1).


oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.

Nickel T, Pfeiler S, Summo C, Kopp R, Meimarakis G, Sicic Z, Lambert M, Lackermair K, David R, Beiras-Fernandez A, Kaczmarek I, Weis M - Mediators Inflamm. (2012)

mRNA expression of CCL21/19, CCR7, and CD83 in vascular plaques compared to aortic tissue without plaque detection. In vivo changes (relative fold increases) in mRNA expression of CCL19, CCL21, CCR7, and CD83 in carotid plaques compared to healthy aortic material. *P < 0.05, **P < 0.01, (n = 47) versus aortic tissue (n = 14).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3350855&req=5

fig1: mRNA expression of CCL21/19, CCR7, and CD83 in vascular plaques compared to aortic tissue without plaque detection. In vivo changes (relative fold increases) in mRNA expression of CCL19, CCL21, CCR7, and CD83 in carotid plaques compared to healthy aortic material. *P < 0.05, **P < 0.01, (n = 47) versus aortic tissue (n = 14).
Mentions: Further analysis of CCL19 revealed that its transcripts were downregulated by 99% (P < 0.01). CCL21 was found 90% lower in the plaque (P < 0.01) compared to healthy aortic tissue (Figure 1).

Bottom Line: CCL21- and CCR7-mRNA levels were significantly downregulated in atherosclerotic plaques versus non-atherosclerotic controls [90% for CCL21 and 81% for CCR7 (P < 0.01)].In vitro, oxLDL reduced CCR7 mRNA levels on DCs by 30% and protein levels by 46%.Furthermore, mRNA expression of CCL21 was significantly reduced by 50% (P < 0.05) and protein expression by 24% in HMECs by oxLDL (P < 0.05).

View Article: PubMed Central - PubMed

Affiliation: Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians University, 81377 Munich, Germany. tsnickel@web.de

ABSTRACT

Introduction: Dendritic cells (DCs) and oxLDL play an important role in the atherosclerotic process with DCs accumulating in the plaques during plaque progression. Our aim was to investigate the role of oxLDL in the modulation of the DC homing-receptor CCR7 and endothelial-ligand CCL21.

Methods and results: The expression of the DC homing-receptor CCR7 and its endothelial-ligand CCL21 was examined on atherosclerotic carotic plaques of 47 patients via qRT-PCR and immunofluorescence. In vitro, we studied the expression of CCR7 on DCs and CCL21 on human microvascular endothelial cells (HMECs) in response to oxLDL. CCL21- and CCR7-mRNA levels were significantly downregulated in atherosclerotic plaques versus non-atherosclerotic controls [90% for CCL21 and 81% for CCR7 (P < 0.01)]. In vitro, oxLDL reduced CCR7 mRNA levels on DCs by 30% and protein levels by 46%. Furthermore, mRNA expression of CCL21 was significantly reduced by 50% (P < 0.05) and protein expression by 24% in HMECs by oxLDL (P < 0.05).

Conclusions: The accumulation of DCs in atherosclerotic plaques appears to be related to a downregulation of chemokines and their ligands, which are known to regulate DC migration. oxLDL induces an in vitro downregulation of CCR7 and CCL21, which may play a role in the reduction of DC migration from the plaques.

Show MeSH
Related in: MedlinePlus